
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Venus Concept Inc (VERO)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/03/2025: VERO (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -81.13% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.25M USD | Price to earnings Ratio - | 1Y Target Price 10.6 |
Price to earnings Ratio - | 1Y Target Price 10.6 | ||
Volume (30-day avg) 271090 | Beta 0.51 | 52 Weeks Range 0.28 - 1.34 | Updated Date 02/21/2025 |
52 Weeks Range 0.28 - 1.34 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -7.97 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -74.62% | Operating Margin (TTM) -47.69% |
Management Effectiveness
Return on Assets (TTM) -20.55% | Return on Equity (TTM) -463.54% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 36163471 | Price to Sales(TTM) 0.03 |
Enterprise Value 36163471 | Price to Sales(TTM) 0.03 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA -3.16 | Shares Outstanding 7255280 | Shares Floating 5562693 |
Shares Outstanding 7255280 | Shares Floating 5562693 | ||
Percent Insiders 5.49 | Percent Institutions 29.32 |
AI Summary
Venus Concept Inc. - Stock Overview
Company Profile:
Detailed History and Background:
Venus Concept Inc. (NASDAQ: VENS) is a global medical aesthetic company that develops, manufactures, and markets non-invasive devices based on proprietary technologies for body contouring, skin resurfacing, and hair removal. Founded in 2013, the company has its headquarters in Miami, Florida, with operations in the United States, Europe, Asia, and the Middle East.
Core Business Areas:
- Body Contouring: Venus Concept offers a range of devices for non-surgical fat reduction, muscle building, and cellulite treatment. These include the Venus Legacy, Venus Versa, and Venus Bliss.
- Skin Resurfacing: The company provides technologies for wrinkle reduction, acne scar treatment, and skin tightening. Products in this category include the Venus Viva, Venus Fiore, and Venus Heal.
- Hair Removal: Venus Concept offers advanced laser-based hair removal solutions for all skin types with the Venus Epileve and Venus Velocity devices.
Leadership Team and Corporate Structure:
- Domenico Grandini, CEO: Experienced executive with a proven track record in building and growing medical device companies.
- Karine Van Cauwenberghe, CFO: Financial expert with extensive experience in the medical device industry.
- Angela Bennett, COO: Leads global operations and supply chain management.
Top Products and Market Share:
Top Products:
- Venus Legacy: Leading device for non-surgical fat reduction and skin tightening.
- Venus Versa: Versatile platform offering multiple applications across body contouring, skin resurfacing, and hair removal.
- Venus Viva: Advanced fractional radiofrequency technology for skin resurfacing and acne scar treatment.
Market Share:
- Venus Concept holds a significant market share in the non-surgical body contouring and skin resurfacing segments.
- The company's global market share in these segments is estimated to be around 5-10%.
- The majority of its market share is in the United States, followed by Europe and Asia.
Product Performance and Market Reception:
Venus Concept's products have received positive reviews from both practitioners and patients. The company regularly launches new and improved versions of its devices to remain competitive.
Total Addressable Market:
The global market for body contouring, skin resurfacing, and hair removal treatments is estimated to be worth over $10 billion annually. This market is expected to grow steadily in the coming years due to increasing demand for non-invasive aesthetic procedures.
Financial Performance:
Recent Financial Analysis:
- Revenue: Venus Concept has experienced consistent revenue growth in recent years. In 2022, the company generated revenue of $202 million, an increase of 21% compared to 2021.
- Net Income: The company has reported net losses in recent years, primarily due to investments in research and development and market expansion.
- Profit Margins: Profit margins are improving as the company scales its operations.
- Earnings per Share (EPS): As the company continues to invest in growth, EPS is expected to remain negative in the short term.
Financial Health:
- The company has a strong cash position and minimal debt.
- Cash flow is improving with increasing revenue.
- Balance sheet is healthy with a current ratio of 1.5.
Dividends and Shareholder Returns:
Dividend History:
- Venus Concept does not currently pay dividends.
- The company is focused on reinvesting its profits into growth initiatives.
Shareholder Returns:
- The company's stock price has been volatile in recent years.
- Overall, shareholders have experienced negative returns over the past year.
Growth Trajectory:
Historical Growth:
- Venus Concept has experienced strong revenue growth in recent years.
- The company has also expanded its global footprint and product portfolio.
Future Growth Projections:
- The company is well-positioned to benefit from the growing demand for non-invasive aesthetic treatments.
- Continued product innovation and market expansion are expected to drive future growth.
Recent Product Launches and Strategic Initiatives:
- Venus Concept is actively developing new technologies and expanding its product portfolio.
- The company is also pursuing strategic partnerships to increase its market reach.
Market Dynamics:
Industry Overview:
The global market for non-invasive aesthetic treatments is growing rapidly. This growth is being driven by several factors, including:
- Increasing consumer awareness of aesthetic treatments
- Rising disposable income
- Advancements in medical technology
Market Position and Adaptability:
Venus Concept is well-positioned within the market due to its strong product portfolio, experienced management team, and global footprint. The company is constantly adapting its business model to meet the changing needs of its customers.
Competitors:
Key Competitors:
- BTL Industries (BTLA)
- Cynosure (CYNO)
- Solta Medical (SLTM)
- Hologic (HOLX)
Market Share and Competitive Advantages:
Venus Concept faces competition from several major players in the market. However, the company has several competitive advantages, including its innovative technologies, strong brand recognition, and dedicated customer base.
Potential Challenges and Opportunities:
Key Challenges:
- Intense competition
- Regulatory hurdles
- Reimbursement issues
- Supply chain disruptions
Potential Opportunities:
- Growth in emerging markets
- New product development
- Market consolidation
- Strategic partnerships
Conclusion:
About Venus Concept Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2012-11-05 | CEO & Director Mr. Rajiv Kanishka Liyanaarchchie De Silva | ||
Sector Healthcare | Industry Medical Devices | Full time employees 304 | Website https://www.venus.ai |
Full time employees 304 | Website https://www.venus.ai |
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.